Regenacy Pharmaceuticals, Inc. Employee Directory

Biotechnology ResearchUnited States2-10 Employees

Regenacy Pharmaceuticals is developing a novel, disease-modifying approach to treating peripheral neuropathies that goes beyond pain and symptom management to restore peripheral nerve function.

Our lead compound ricolinostat (ACY-1215) is an oral, selective inhibitor of the microtubule modifying enzyme HDAC6 with first-in-class potential, currently positioned to enter Phase 2 clinical trials. Our investigation of ricolinostat for diabetic, chemotherapy-induced and inherited peripheral neuropathies is based on compelling proof-of-concept preclinical studies demonstrating restoration of normal nerve function. 

We were founded in December 2016 following the acquisition of Acetylon Pharmaceuticals by Celgene. Regenacy received exclusive rights to ricolinostat, a clinical stage, orally bioavailable, HDAC6 selective inhibitor, for a range of non-cancer disease indications. We also have a unique and proprietary portfolio of selective HDAC1,2 inhibitors with potential for treating cancer, hemoglobinopathies, and cognitive dysfunction.

Find Regenacy Pharmaceuticals, Inc. employees' phone numbers or email addresses

Regenacy Pharmaceuticals, Inc. Global Highlights

Location
Employees

North America
3

Minus sign iconPlus sign icon
  • United States Of America
    3

Asia
1

Minus sign iconPlus sign icon
  • China
    1

Regenacy Pharmaceuticals, Inc.'s Leadership

  • Stylized image of a person
    T. K.
    Avp Regulatory Affairs And Quality Assurance
    Phone icon
  • Stylized image of a person
    Y. J.
    Board Observer
    Phone icon
  • Stylized image of a person
    D. H.
    Scientific Advisory Board
    Phone icon

Contact profiles from Regenacy Pharmaceuticals, Inc.

Name
Title
Contact Info
Location
Last Update
  • Stylized image of a person
    T. K.
    Avp Regulatory Affairs And Quality Assurance
    Phone icon
    United StatesNew Hampshire
    Sep 09, 2025
  • Stylized image of a person
    Y. J.
    Board Observer
    Phone icon
    ChinaShanghai
    Oct 19, 2025
  • Stylized image of a person
    D. H.
    Scientific Advisory Board
    Phone icon
    United StatesNew York
    Oct 17, 2025

Frequently Asked Questions

What is Regenacy Pharmaceuticals, Inc. known for?

Minus sign iconPlus sign icon
Regenacy Pharmaceuticals, Inc. was founded in 2016 operates in the Biotechnology Research industry. The company's main headquarters is located in 303 Wyman St, Waltham, Massachusetts 02451, US; you can contact the main corporate office by phone at . Explore Regenacy Pharmaceuticals, Inc.'s company overview page for more information.

What is Regenacy Pharmaceuticals, Inc.'s most common email format?

Minus sign iconPlus sign icon
Regenacy Pharmaceuticals, Inc. employees' email format typically follows the pattern of . Trying to find reliable and up-to-date employee contact data? Find more Regenacy Pharmaceuticals, Inc. email formats with LeadIQ.

How many employees does Regenacy Pharmaceuticals, Inc. have currently?

Minus sign iconPlus sign icon
Regenacy Pharmaceuticals, Inc. has approximately 6 employees as of December 2025. These team members are located across 2 continents, including North AmericaAsia.

Who are Regenacy Pharmaceuticals, Inc.'s key employees and leadership?

Minus sign iconPlus sign icon

As of December 2025, Regenacy Pharmaceuticals, Inc.'s key employees include:

  • Avp Regulatory Affairs And Quality Assurance: T. K.
  • Board Observer: Y. J.
  • Scientific Advisory Board: D. H.

Looking for contact data? Unlock accurate emails and phone numbers for your ideal prospects with LeadIQ.

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.